Research & Development

NIH Announces 8-Year Hepatitis Therapy Study

Published in Hepatitis Weekly, August 16th, 1999

An eight-year study designed to test antiviral drug therapies has been announced by the U.S. National Institutes of Health.

The $28 million clinical trial will be funded by the National Institute of Diabetes and Digestive and Kidney Diseases, a division of NIH.

Researchers will try to determine if long-term treatment with drugs can slow or prevent the progression of liver disease in hepatitis C patients. The trials are scheduled to begin next year at nine centers around the country, NIH officials said.

Researchers will decide this summer which drugs will be used and the number of volunteers to be recruited. Hepatitis C infection...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (1999-08-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry